RGC
Regencell Bioscience Holdings LHealthcare$30.80
▲ Bullish
Mkt Cap: $15.23B|Float: 55.4M|SI: 1.1%|DTC: 5.0
Data as of market close Apr 2, 2026
IV Rank
92
IV Pctl
78%
HV 20d
11116.0%
52W Range
$1-$84
ATR(14)
$3.26
Exp. Move
±29.9%
P/C Ratio
1.15
Earnings
Jun 2
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
RGC Key Options Data
- IV Rank
- 92%
- Total GEX
- $0.00B
- Total DEX
- $0.1M
- Max Pain
- $30.00
- Expected Move
- ±29.9%
- Put/Call OI
- 1.15
- Net Premium
- $0.0M
- Spot Price
- $30.80
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$9.20 | ±29.9% | $21.60 | $40.00 |
| 2026-05-15 | 43 | ±$5.00 | ±16.2% | $25.80 | $35.80 |
| 2026-06-18 | 77 | ±$17.40 | ±56.5% | $13.40 | $48.20 |
| 2026-09-18 | 169 | ±$21.50 | ±69.8% | $9.30 | $52.30 |
Explore RGC options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.